Vimarsana
Biggest News Aggregation in the World

Page 3 - Peter Lio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peter Lio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peter Lio Today - Breaking & Trending Today

The Pharmacological Aspects of Adalimumab Biosimilars - Vimarsana News

The Pharmacological Aspects of Adalimumab Biosimilars

A clinical pharmacist reviews the various pharmacological aspects of the available adalimumab biosimilars.

An Overview of Adalimumab Biosimilars - Vimarsana News

An Overview of Adalimumab Biosimilars

Clinicians and a pharmacist provide an overview of the emerging adalimumab biosimilars in the recent years.

The Need for Biosimilars in Inflammatory Diseases and Regulatory Requirements for Approval - Vimarsana News

The Need for Biosimilars in Inflammatory Diseases and Regulatory Requirements for Approval

Drs Lio, Botsoglou, and Axelrad discuss the need for biosimilars in inflammatory diseases, and clinical pharmacist Dr Humphreys reviews the regulatory requirements for biosimilars to receive FDA approval.

Atopic dermatitis: How climate change can affect eczema - Vimarsana News

Atopic dermatitis: How climate change can affect eczema

Scientists say climate change issues such as global warming can exacerbate the symptoms of atopic dermatitis, a skin condition also known as eczema

Access to JAK Inhibitors in AD - Vimarsana News

Access to JAK Inhibitors in AD

Lisa Swanson, MD, PhD, highlights dermatology biologics coordinators as a resource for getting better access to JAK inhibitors.